GMED (GMED) holder files to sell 2,000 shares after RSU vesting

Rhea-AI Filing Summary

GMED insider plans a small stock sale under Rule 144. A holder, identified as Leslie Norwalk, has filed to sell up to 2,000 shares of GMED common stock on the NYSE through Raymond James & Associates, with an indicated aggregate market value of $202,000. GMED had 133,839,166 common shares outstanding at the time listed.

The shares to be sold come from 10,000 common shares acquired on 09/01/2023 through RSU vesting from the issuer. Over the prior three months, the same seller disposed of 4,000 common shares on 12/12/2025 for gross proceeds of $355,188.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	2000	202000.00	133839166	01/08/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/01/2023	RSU Vesting	Issuer			10000	09/01/2023	RSU Vesting

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Leslie Norwalk 7025 Arbor Ln McLean VA 22101	Common	12/12/2025	4000	355188.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many GMED shares are planned to be sold under this Form 144?

The notice covers up to 2,000 shares of GMED common stock planned to be sold on the NYSE, with an indicated aggregate market value of $202,000.

Who is the GMED insider or holder selling shares in this Form 144?

The seller identified in the filing is Leslie Norwalk, for whose account the GMED common stock is to be sold.

How and when were the GMED shares being sold under Form 144 acquired?

The common shares were acquired via RSU vesting from the issuer on 09/01/2023, when 10,000 GMED shares vested.

What prior GMED stock sales has this seller made in the last three months?

During the past three months, the seller disposed of 4,000 GMED common shares on 12/12/2025, generating gross proceeds of $355,188.

Which broker and exchange will be used for this GMED Form 144 sale?

The planned sale will be executed through Raymond James & Associates, with trading on the NYSE as stated in the filing.

How many GMED shares were outstanding at the time referenced in this Form 144?

The filing lists 133,839,166 GMED common shares as outstanding, providing a baseline figure relative to the planned sale.

What is the approximate date of the planned GMED share sale in this Form 144?

The approximate date of sale given in the notice is 01/08/2026 for the 2,000 GMED common shares covered.